Literature DB >> 2297480

Interactions at the blood/material interface.

H P Greisler1.   

Abstract

The complex interactions occurring at the blood/material interface of implanted blood-contacting biomaterials largely determine the clinical efficacy of small diameter vascular grafts. Physical characteristics of the material such as chemical composition, electrical charge, surface texture, elastic modulus, and porosity all affect many responses at the interfaces with blood, surrounding tissues, and adjacent artery. Some responses begin instantaneously (deposition of plasma proteins and platelets) while other reactions are somewhat delayed (deposition of leukocytes and monocytes, and migration of endothelial cells and smooth muscle cells). Each of these elements may become activated and release bioactive substances which further affect the behavior of the other entities in this complex and dynamic microenvironment. It is precisely these tissue reactions that regulate thrombogenicity and the development of pseudointimal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297480     DOI: 10.1007/BF02042699

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  18 in total

1.  Metal mesh scaffold for tissue engineering of membranes.

Authors:  S Hamed Alavi; Arash Kheradvar
Journal:  Tissue Eng Part C Methods       Date:  2011-12-22       Impact factor: 3.056

2.  A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants.

Authors:  Adinarayana Andukuri; Meenakshi Kushwaha; Ajay Tambralli; Joel M Anderson; Derrick R Dean; Joel L Berry; Young Doug Sohn; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Acta Biomater       Date:  2010-08-20       Impact factor: 8.947

3.  Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells.

Authors:  M Preis; J Schneiderman; B Koren; Y Ben-Yosef; D Levin-Ashkenazi; S Shapiro; T Cohen; M Blich; M Israeli-Amit; Y Sarnatzki; D Gershtein; R Shofti; B S Lewis; Y Shaul; M Y Flugelman
Journal:  Gene Ther       Date:  2015-12-24       Impact factor: 5.250

4.  Characterization of endothelial basement membrane nanotopography in rhesus macaque as a guide for vessel tissue engineering.

Authors:  Sara J Liliensiek; Paul Nealey; Christopher J Murphy
Journal:  Tissue Eng Part A       Date:  2009-09       Impact factor: 3.845

5.  Improved Patency of ePTFE Grafts as a Hemodialysis Access Site by Seeding Autologous Endothelial Cells Expressing Fibulin-5 and VEGF.

Authors:  Itai Tzchori; Mizied Falah; Denis Shteynberg; Dana Levin Ashkenazi; Zeev Loberman; Luba Perry; Moshe Y Flugelman
Journal:  Mol Ther       Date:  2018-04-05       Impact factor: 11.454

6.  Development of the novel biotube inserting technique for acceleration of thick-walled autologous tissue-engineered vascular grafts fabrication.

Authors:  Ning Ma; Zhenyu Wang; Hao Chen; Yanjun Sun; Haifa Hong; Qi Sun; Meng Yin; Jinfen Liu
Journal:  J Mater Sci Mater Med       Date:  2011-02-18       Impact factor: 3.896

7.  End-point immobilization of heparin on plasma-treated surface of electrospun polycarbonate-urethane vascular graft.

Authors:  Xuefeng Qiu; Benjamin Li-Ping Lee; Xinghai Ning; Niren Murthy; Nianguo Dong; Song Li
Journal:  Acta Biomater       Date:  2017-01-06       Impact factor: 8.947

Review 8.  Biomaterials for vascular tissue engineering.

Authors:  Swathi Ravi; Elliot L Chaikof
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

Review 9.  Polymeric materials for tissue engineering of arterial substitutes.

Authors:  Swathi Ravi; Zheng Qu; Elliot L Chaikof
Journal:  Vascular       Date:  2009 May-Jun       Impact factor: 1.285

10.  A hypothesis-driven parametric study of effects of polymeric scaffold properties on tissue engineered neovessel formation.

Authors:  Kristin S Miller; Ramak Khosravi; Christopher K Breuer; Jay D Humphrey
Journal:  Acta Biomater       Date:  2014-10-05       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.